ISRCTN75639135Completed未知
Hamstrings graft donor site infiltration with bupivacaine for pain relief after arthroscopically assisted anterior cruciate ligament reconstruction
Record Provided by the NHSTCT Register - 2007 Update - Department of Health0 sites50 target enrollmentStarted: September 28, 2007Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients having primary anterior cruciate ligament reconstruction with hamstrings ipsilateral hamstrings tendon graft, under spinal anaesthesia
Exclusion Criteria
- •1. Patients unwilling to participate
- •2. Those undergoing any procedure other than that described as inclusion criteria
- •3. Patients unable to consent for themselves
- •4. Patients with a known allergy to bupivacaine
- •5. Patients with peripheral neuropathy
Investigators
Similar Trials
Active, not recruiting
Phase 1
Hamstrings Graft Donor Site Infiltration with Bupivacaine for Pain Relief after Arthroscopically Assisted Anterior Cruciate Ligament Reconstruction - Hamstrings graft donor site pain relief after ACL reconstructioAnterior Cruciate Ligament ReconstructionEUCTR2006-001556-12-GBDerby Hospitals NHS Foundation Trust
Completed
Not Applicable
ViabAhn steNt graft placement for superficial femoral artery disease reQUIring endovaScular tHerapy -Prospective multicenter registryPADJPRN-UMIN000028255Kansai Rosai Hospital500
Completed
Not Applicable
Percutaneous fixation with bone grafting through the distal screw insertion hole for the treatment of scaphoid nonunioScaphoid nonunionJPRN-UMIN000018105Kyoto University Hospital15
Completed
Not Applicable
Treatment of retracted gums using tissues which underline the roof of the mouth with two surgical scalpelsGingival recession of Miller's class IOral HealthISRCTN34968827Damascus University12
Active, not recruiting
Phase 1
ncemented total hip implant and subcutaneous injection of Denosumab for patients with degenerative joint disease of the hip. A randomised double blind placebo controlled study on the effects on bone evaluated with bone densitometry, uptake of Fluoride isotop measure with Positron Emission Tomography and Computed Tomography, and blood samples analyzed for bone turnover.Patients with osteoarthritis of the hip treated with an uncemented total hip arthroplasty. This procedure is accompanied with an increased risk for loss of bone adjacent to the implantsEUCTR2011-001481-18-SEppsala University Hospital64